Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4220
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-4220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Figure1)
This text contains statistical data related to a research study, including cumulative incidence percentages for different groups and the number at risk in each group. The data also shows confidence intervals and significant p-values. The information provided seems to be related to a medical or scientific study evaluating a treatment or intervention compared to a placebo.*
Figure2 (Figure2)
This is a statistical analysis of the effectiveness of Rosuvastatin 20 mg compared to placebo based on the occurrence of various cardiovascular events in a group of 8901 patients. The results show significant reductions in the primary endpoint (MCE), cardiovascular death, non-fatal stroke, non-fatal myocardial infarction (MI), and arterial revascularization in the Rosuvastatin group compared to placebo. The hazard ratios (HR) and confidence intervals (95% CI) for each event are provided along with the corresponding P values.*
Figure3 (Figure3)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.